orphan drugs

EMA Backs Three Orphan Drugs

Three of six new meds to be approved in Europe are orphan drugs and have been backed by the European Medicines Agency (EMA) this month. The EMA’s Committee for Medicinal Products for Human Use (CHMP) has recommended authorisation...
Vygon Group

Enteral feeding: Vygon Group launches safe-enteral.com

Vygon is keen to raise awareness amongst medical staff about the benefits of new standardized enteral connectors and the potential risks when used in premature neonates Ecouen, France, April 25, 2017 – Vygon, the single-use...
drug cost pharma ad pharmaceutical ad

Prescription Drug Costs Are On The Rise; So Are The TV Ads Promoting Them

Laura Ries was moved to action when she saw a TV commercial that portrayed a woman enjoying time with her grandchildren after taking Lyrica, a prescription medication for diabetic nerve pain. Ries’ elderly mother...
Fosun Pharmaceuticals

FIPB Clears Fosun – Gland Pharma Deal

Shanghai Fosun Pharmaceuticals (Group) Co. Ltd has received approval from Foreign Investment Promotion Board (FIPB) to pick up a majority stake in Hyderabad-based Gland Pharma Ltd. The China-based pharmaceuticals company had agreed to acquire an...
Domain Therapeutics

Domain Therapeutics and Pfizer Inc. enter into collaboration agreement on bioSensAll™

Strasbourg, France, and Montreal, Canada, April 25, 2017 - Domain Therapeutics, a France- and Quebec-based biopharmaceutical company specializing in the research and development of new drug candidates that target G protein-coupled receptors (GPCRs), today...
Glenmark

Glenmark Gets USFDA Nod For Anti-Cholesterol Drug

Drug firm Glenmark Pharmaceuticals today said it has received final approval from the USFDA for its generic version of Fenofibrate capsules used for lowering cholesterol. The company has been granted final approval by the United...
Pharmaceutical

California Presses Forward In Fight To Regulate Pharmaceutical Companies

In November, California voters defeated a ballot proposal that would have given state government more control over drug prices. It was a victory for pharmaceutical companies, which spent more than $100 million campaigning against the measure. Now the industry...
Ocrevus

USFDA Approved Ocrevus To Treat Multiple Sclerosis

THERAPEUTIC ADVANCE The United States Food and Drug Administration has approved Ocrevus (ocrelizumab) to treat adult patients with relapsing forms of multiple sclerosis (MS) and primary progressive multiple sclerosis (PPMS). This is the first drug...
abbott

Abbott’s Stent Faces Another Storm, This Time On Safety

Even as healthcare major Abbott's bio-absorable stent ‘Absorb' battles price control challenges in India, another storm seems to be blowing in from Europe. The healthcare multinational has sent a letter to doctors in Europe informing...
ATUM

ATUM Launches Cell-Line Development Service

Newark, USA, 10th April 2017 / ATUM (formerly DNA2.0) has announced an expansion of its services to include cell line development, which has been enabled by the company’s proprietary Leap-In Transposase genome engineering tools.  ATUM...